Approach
There is no specific antiviral therapy available for mumps. Given that the disease is usually benign and self-limited, the focus of treatment is on supportive care and symptom relief, primarily through the use of analgesics and antipyretics.
People with mumps should be isolated to prevent the spread of the infection. The American Academy of Pediatrics (AAP), Centers for Disease Control and Prevention (CDC), and Healthcare Infection Control Practices Advisory Committee (HICPAC) all recommend a 5-day period after onset of parotitis, both for isolation of people with mumps in either community or healthcare settings, and for use of standard precautions and droplet precautions.[43] In the UK, exclusion from school or work is also recommended for 5 days.[44] Healthcare professionals with no evidence of mumps immunity who are exposed to patients with mumps should be excluded from duty from the 12th day after first exposure through the 26th day after last exposure.[43] Local guidelines should be consulted.
Mumps immunoglobulin is not thought to be helpful in the prophylaxis or the treatment of active disease and is no longer available in most countries.
Use of this content is subject to our disclaimer